Home > Oncology > ELCC 2019 > Current Management of Early Stage NSCLC > Tumour, node, and metastasis (TNM) staging system

Tumour, node, and metastasis (TNM) staging system

Presented By
Dr Walter Weder, Dr Ramón Rami-Porta
Conference
ELCC 2019
The TNM classification is still crucial for our decision-making process in curable (local or locally advanced) non-small cell lung cancer (NSCLC). The N-stage has to be carefully assessed before deciding to start neoadjuvant or adjuvant therapy, said Dr Walter Weder (University Hospital Zurich, Switzerland). Invasive mediastinal staging is necessary in early stage lung cancer, in case of unclear stage after careful imaging, in case of doubt that a curative approach is reasonable due to the exact stage of the disease, or in case neoadjuvant therapy is planned for downstaging. However, mediastinal staging is invasive, which carries potential risks of morbidity and mortality, and may unnecessarily delay curative treatment. Decision on when to carry out invasive mediastinal staging may still vary among institutions and caregivers. In 2015, the International Association for the Study of Lung Cancer Lung Cancer Staging Project made some proposals for the revisio...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on